Dow Pharmaceutical Sciences Inc.

Complex generic drug sponsors now can track the US Food and Drug Administration's plans for new and revised product-specific guidances and potentially avoid development or application assessment setba

Complex generic drug sponsors now can track the US Food and Drug Administration's plans for new and revised product-specific guidances and potentially avoid development or application assessment setba

Over the last five years Valeant Pharmaceuticals International Inc. has gone from a small Canadian dermatology company to a large multi-national conglomerate. This transformation was due to CEO Mi

The "troubling" trends in the rising costs to US consumers of prescription drugs, including generics, is a big yellow warning sign the biopharmaceutical market is out of balance, largely due to a lack